Antibacterial Nanoparticles Therapeutic (ANT) Study
Award Notice Posted
- Solicitation number
- HT9426-26-C-E018
- Agency
- Not on record
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HT9426-26-C-E018
- NAICS code
- 541713 Research and Development in Nanotechnology
- Place of performance
- Silver Spring, Maryland 20910, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Walter Reed Army Institute of Research awarded a sole-source contract valued at $295,460 to University of Notre Dame Du Lac on August 19, 2026, for an R&D study testing antibacterial nanoparticles with phage-mimicking properties against multi-drug resistant Pseudomonas aeruginosa strains relevant to combat-related infections in service members.
The award followed a Request for Information posted March 18, 2026, which yielded three responses; two were deemed technically incapable and Notre Dame was determined capable. A subsequent Notice of Intent posted April 14, 2026, generated no responses. Market research supported the non-commercial, FAR Part 13 sole-source determination. Contract number HT9426-26-C-E018 was awarded under no set-aside.
Notice text
The Walter Reed Army Institute of Research (WRAIR), Bacterial Diseases Branch (BDB)seeks to conduct a Research and Development (R&D) study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. A RFI was posted pm sam.gov’s GPE on 18 March 2026 and closed on 1 April 2026, three responses were received, and the Contracting Officer’s Representative preformed a technical evaluation, two of the responses were deemed not capable for the requirement, and one, The University of Notre Dame, was deemed capable for the requirement. A Notice of Intent was posted on sam.gov’s GPE on 14 April 2026, with a closing date of 28 April 2026. No responses were received. Therefore, market research determined a non-commercial FAR RFO Part 13 sole source award to the University of Notre Dame to be in the best interest of the Government.
Awarded contract HT9426-26-C-E018 to UNIVERSITY OF NOTRE DAME DU LAC for 295460.00 on 2026-08-19.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Antibacterial Nanoparticles Therapeutic (ANT) Study | Special Notice | |
| Antibacterial Nanoparticles Therapeutic (ANT) Study | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity